Top stories in endocrinology: switch from analogue to insulin reduces part D coverage gap, #MeToo era highlights need to address disparities and harassment

Among the top stories in endocrinology is the need to work harder to address gender disparities and reports of harassment in the #MeToo era. Medicare beneficiaries with type 2 diabetes who switched from analogue to human insulin were less likely to reach the spending limit for their Part D drug plan. Other top stories include a 10-week treatment with a higher dose of hydrocortisone lowered the metabolism of tryptophan for patients with secondary adrenal insufficiency, transgender women who initiated cross-sex estrogen therapy were at increased risk for acute cardiovascular events compared